Compare Enveric Biosciences Inc (ENVB) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs 22nd Century Group Inc — how do they compare? Enveric Biosciences Inc trades at $1.56 (market cap $6.20M), while 22nd Century Group Inc trades at $4.46 (market cap $1.52M). The key difference: Enveric Biosciences Inc is far larger — about 4.1× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| ENVB | XXII | |
|---|---|---|
Market Cap | $6.20M | $1.52M |
Sector | Health | Technology |
52-Week High | $17.40 | $801.00 |
52-Week Low | $1.27 | $3.72 |
Enterprise Value | $1.30M | -$6.71M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
